REFERENCES
- Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002; 27: 391–401
- Ammon H P, Wahl M A. Pharmacology of curcuma longa. Planta Med 1991; 57: 1–7
- Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar S V, Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochem Pharmacol 2004; 68: 2043–2052
- Chearwae W, Wu C P, Chu H Y, Lee T R, Ambudkar S V, Limtrakul P. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol 2006; 57: 376–388
- Coxeter P D, McLachlan A J, Duke C C, Roufogalis B D. Herb-drug interactions: an evidence based approach. Curr Med Chem 2004; 11: 1513–1525
- De Smet P A. Health risks of herbal remedies: an update. Clin Pharmacol Ther 2004; 76: 1–17
- Delgoda R, Westlake A C. Herbal interactions involving cytochrome P450 enzymes: a mini review. Toxicol Rev 2004; 23: 239–249
- Deshpande S S, Lalitha V S, Ingle A D, Raste A S, Gadre S G, Maru G B. Subchronic oral toxicity of turmeric and ethanolic turmeric extract in female mice and rats. Toxicol Lett 1998; 95: 183–193
- Heck A M, DeWitt B A, Lukes A L. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000; 57: 1221–1227
- Ho R H, Kim R B. Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther 2005; 78: 260–277
- Izzo A A. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 2005; 19: 1–16
- Joshi J, Ghaisas S, Vaidya A, Vaidya R, Kamat D V, Bhagwat A N, Bhide S. Early human safety study of turmeric oil (curcuma longa oil) administered orally in healthy volunteers. J Assoc Physicians India 2003; 51: 1055–1060
- Kandarkar S V, Sawant S S, Ingle A D, Deshpande S S, Maru G B. Subchronic oral hepatotoxicity of turmeric in mice-histopathological and ultrastructural studies. Indian J Exp Biol 1998; 36: 675–679
- Limtrakul P, Anuchapreeda S, Buddhasukh D. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 2004; 4: 13
- Luper S. A review of plants used in the treatment of liver disease: part two. Altern Med Rev 1999; 4: 178–188
- Maheshwari R K, Singh A K, Gaddipati J, Srimal R C. Multiple biological activities of curcumin: a short review. Life Sci 2006; 78: 2081–2087
- Shah B H, Nawaz Z, Pertani S A, Roomi A, Mahmood H, Saeed S A, Gilani A H. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2 + signaling. Biochem Pharmacol 1999; 58: 1167–1172
- Soons P A, Schellens J H, Roosemalen M C, Breimer D D. Analysis of nifedipine and its pyridine metabolite dehydronifedipine in blood and plasma: review and improved high-performance liquid chromatographic methodology. J Pharm Biomed Anal 1991; 9: 475–484
- Tabata K, Yamaoka K, Kaibara A, Suzuki S, Terakawa M, Hata T. Moment analysis program available on Microsoft Excel®. Xenobio Metabol and Dispos 1999; 14: 286–293
- Takara K, Sakaeda T, Tanigawara Y, Nishiguchi K, Ohmoto N, Horinouchi M, Komada F, Ohnishi N, Yokoyama T, Okumura K. Effects of 12 Ca2 + antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression. Eur J Pharm Sci 2002; 16: 159–165
- Valentine S P, Le Nedelec M J, Menzies A R, Scandlyn M J, Goodin M G, Rosengren R J. Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse. Life Sci 2006; 78: 2391–2398
- Waller D G, Renwick A G, Gruchy B S, George C F. The first pass metabolism of nifedipine in man. Br J Clin Pharmacol 1984; 18: 951–954
- Wilkinson G R. The dynamics of drug absorption, distribution, and elimination. Goodman and Gilman's the pharmacological basis of therapeutics, tenth edition, J G Hardman, L E Limbird. McGraw-Hill, New York 2001; 3–29
- Yoshioka M, Ohnishi N, Sone N, Egami S, Takara K, Yokoyama T, Kuroda K. Studies on interactions between functional foods or dietary supplements and medicines. III. Effects of ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats. Biol Pharm Bull 2004; 27: 2042–2045
- Zhang W, Tan T M, Lim L Y. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab Dispos 2007; 35: 110–115